Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,630 total articles

Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program

Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program

Royalty Pharma announced a $7.5 million donation to Blood Cancer United's Therapy Acceleration Program (TAP) aimed at accelerating the development of blood cancer therapies by funding early-stage biotech companies. This commitment enhances Royalty Pharma's ongoing collaboration with Blood Cancer United, supporting innovation and efforts to bring ne…

Ryman Hospitality Properties, Inc. Declares Third Quarter Dividend

Ryman Hospitality Properties, Inc. Declares Third Quarter Dividend

Ryman Hospitality Properties, a REIT specializing in upscale convention center resorts and entertainment experiences, declared a third quarter cash dividend of $1.20 per share payable October 15, 2026. The company manages key assets including five of the largest non-gaming convention center hotels in the U.S. and a controlling interest in Opry Ente…

Flag Ship Acquisition Corporation Announces Definitive Business Combination Agreement with Bluechip & Co. Holdings

Flag Ship Acquisition Corporation Announces Definitive Business Combination Agreement with Bluechip & Co. Holdings

Flag Ship Acquisition Corporation, a Nasdaq-listed SPAC, has entered into a definitive merger agreement with Bluechip & Co. Holdings, a Cayman Islands holding company specializing in insurance-related customer acquisition, financial education, U.S. capital markets advisory, AI-driven online advertising, and data-center services. Upon completion, Bl…

Lineage, Inc. Declares Dividend for Third-Quarter 2026

Lineage, Inc. Declares Dividend for Third-Quarter 2026

Lineage, Inc., the world's largest global temperature-controlled warehouse REIT, declared a cash dividend of $0.5325 per share for Q3 2026, payable October 21, 2026. The company maintains a vast network of facilities across North America, Europe, and Asia-Pacific, serving major food and beverage producers and retailers. The dividend announcement un…

SiriusPoint Appoints Rachel Winoski as Chief Human Resources Officer

SiriusPoint Appoints Rachel Winoski as Chief Human Resources Officer

SiriusPoint Ltd., a global specialty underwriter listed on the NYSE, has appointed Rachel Winoski as Chief Human Resources Officer effective October 5, 2026. Winoski brings over 15 years of HR experience in the insurance industry, most recently from AXA XL, and will join the Executive Leadership Team to enhance organizational culture and talent man…

SPX Technologies Announces Acquisition of FIS Water

SPX Technologies Announces Acquisition of FIS Water

SPX Technologies has completed the acquisition of FIS Water for approximately $410 million in cash. FIS Water, established in 2018, offers engineered water management solutions primarily for commercial and industrial cooling systems, complementing SPX's existing Cooling platform. The acquisition integrates FIS Water into SPX's HVAC segment, enhanci…

FTAI Aviation Announces $500 Million Share Repurchase Program

FTAI Aviation Announces $500 Million Share Repurchase Program

FTAI Aviation Ltd. announced that its board authorized a share repurchase program allowing the company to buy back up to $500 million of its outstanding shares by September 30, 2029. Funded by existing cash reserves, the repurchases may occur under various methods depending on market conditions and regulations. This move aims to support the company…

Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform

Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform

Tempest Therapeutics announced an exclusive option agreement with Hebei Senlang Biotechnology to license a CD7-targeted lentiviral vector platform for in vivo CAR-T therapies. The lentiviral platform complements Tempest's existing lipid nanoparticle CAR-T delivery system, aiming to provide durable CAR-T treatments for oncology and autoimmune diseas…